Clinical trial
Evaluation in Routine Practice of the Benefits of Sublingual Allergen Immunotherapy in Allergic Patients According to Different Modalities of Use
NCT06574061 is registered in ClinicalTrials.gov with Stallergenes Greer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation in Routine Practice of the Benefits of Sublingual Allergen Immunotherapy in Allergic Patients According to Different Modalities of Use
- Lead sponsor
- Stallergenes Greer
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 29, 2018
- Completion date
- October 14, 2021
- Enrollment
- 1,635 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allergic rhinitis